{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:40:25Z","timestamp":1739961625646,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1124\/mol.110.067728","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T04:45:25Z","timestamp":1285649125000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular Determinants of Human ether-\u00e0-go-go-Related Gene 1 (hERG1) K+ Channel Activation by NS1643"],"prefix":"10.1016","volume":"79","author":[{"given":"Morten","family":"Grunnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Abbruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank B.","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.067728_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/mol.105.019943","article-title":"Mechanism of action of a novel human ether-a-go-go-related gene channel activator","volume":"69","author":"Casis","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib2","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1074\/jbc.274.15.10113","article-title":"Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067728_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"10.1124\/mol.110.067728_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.hrthm.2008.10.020","article-title":"Antiarrhythmic effect of IKr activation in a cellular model of LQT3","volume":"6","author":"Diness","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1124\/mol.110.067728_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvn075","article-title":"Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome","volume":"79","author":"Diness","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1124\/mol.110.067728_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/mol.109.059543","article-title":"Pharmacological removal of human ether-\u00e0-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574)","volume":"77","author":"Gerlach","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/mol.107.041152","article-title":"2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels","volume":"73","author":"Gordon","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000185545","article-title":"Biophysical characterization of the short QT mutation hERG-N588K reveals a mixed gain-and loss-of-function","volume":"22","author":"Grunnet","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/mol.110.067728_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/mol.105.015859","article-title":"Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643)","volume":"69","author":"Hansen","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1124\/mol.106.026492","article-title":"Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N\u2032-(3\u2032-trifluoromethylphenyl)urea]","volume":"70","author":"Hansen","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/jpet.106.118448","article-title":"Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart","volume":"321","author":"Hansen","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.110.067728_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/FJC.0b013e31817dd013","article-title":"In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig","volume":"52","author":"Hansen","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/mol.110.067728_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.01.016","article-title":"Use and abuse of QT and TRIaD in cardiac safety research: importance of study design and conduct","volume":"584","author":"Hondeghem","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.110.067728_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/mol.104.006577","article-title":"Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel","volume":"67","author":"Kang","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00424-008-0476-7","article-title":"Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the I (Kr) current","volume":"456","author":"Larsen","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1124\/mol.110.067728_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1540-8167.2010.01733.x","article-title":"Pharmacological activation of IKr impairs conduction in guinea pig hearts","volume":"21","author":"Larsen","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1124\/mol.110.067728_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/01.RES.81.5.719","article-title":"Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts","volume":"81","author":"Lees-Miller","year":"1997","journal-title":"Circ Res"},{"key":"10.1124\/mol.110.067728_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.RES.81.5.870","article-title":"Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current","volume":"81","author":"London","year":"1997","journal-title":"Circ Res"},{"key":"10.1124\/mol.110.067728_bib19","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjp.2008.191","article-title":"Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines","volume":"154","author":"Lu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.110.067728_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)81635-9","article-title":"Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain","volume":"95","author":"Morais Cabral","year":"1998","journal-title":"Cell"},{"key":"10.1124\/mol.110.067728_bib21","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1161\/01.CIR.92.10.2929","article-title":"ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome","volume":"92","author":"Moss","year":"1995","journal-title":"Circulation"},{"key":"10.1124\/mol.110.067728_bib22","doi-asserted-by":"crossref","first-page":"20075","DOI":"10.1073\/pnas.0906597106","article-title":"PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance","volume":"106","author":"Perry","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067728_bib23","doi-asserted-by":"crossref","first-page":"13827","DOI":"10.1073\/pnas.0703934104","article-title":"Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator","volume":"104","author":"Perry","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067728_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1124\/mol.110.067728_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1124\/mol.110.067728_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2005.01.003","article-title":"Predicting drug-hERG channel interactions that cause acquired long QT syndrome","volume":"26","author":"Sanguinetti","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.110.067728_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1124\/mol.110.067728_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bcp.2009.01.015","article-title":"Electrophysiologic characterization of a novel hERG channel activator","volume":"77","author":"Su","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.110.067728_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"HERG, a human inward rectifier in the voltage-gated potassium channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science"},{"key":"10.1124\/mol.110.067728_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1124\/mol.110.067728_bib31","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1073\/pnas.91.8.3438","article-title":"A family of potassium channel genes related to eag in Drosophila and mammals","volume":"91","author":"Warmke","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067728_bib32","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1124\/mol.108.045591","volume":"73","author":"Xu","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067728_bib33","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/S0006-3495(03)70028-9","article-title":"BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1","volume":"84","author":"Zhang","year":"2003","journal-title":"Biophys J"},{"key":"10.1124\/mol.110.067728_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/mol.105.014035","article-title":"Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity","volume":"68","author":"Zhou","year":"2005","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.067728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:49:13Z","timestamp":1739958553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24028529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0026895X24028529"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.067728","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Determinants of Human ether-\u00e0-go-go-Related Gene 1 (hERG1) K+ Channel Activation by NS1643","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.067728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}